|
Oct 10
|
Cancer Biotechs Pique Buyout Interest: Recent Deals in Focus
|
|
Oct 10
|
Tango Therapeutics (TNGX) Rises 20% in a Month: Here's Why
|
|
Oct 10
|
Why Shares of Lexicon Pharmaceuticals Are Up Tuesday
|
|
Oct 10
|
Health Care Roundup: Market Talk
|
|
Oct 9
|
Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors
|
|
Oct 9
|
Tesla, Bristol Myers-Mirati deal, Alnylam Pharma: Top Tickers
|
|
Oct 9
|
These Stocks Are Moving the Most Today: Exxon, Lockheed, Northrop, Delta, Mirati, Alnylam, SolarEdge, and More
|
|
Oct 9
|
Bristol Myers to buy cancer specialist Mirati for up to $5.8 billion
|
|
Oct 9
|
Bristol-Myers Squibb Buys Mirati Therapeutics to Boost Cancer Drug Portfolio
|
|
Oct 9
|
Bristol Myers Squibb to buy cancer drugmaker Mirati Therapeutics in up to $5.8B deal
|
|
Oct 9
|
Bristol Myers (BMY) to Acquire Mirati Therapeutics for $5.8 B
|
|
Oct 9
|
Bristol-Myers Squibb to acquire Mirati in deal worth up to $5.8B
|
|
Oct 9
|
Mirati (MRTX) Gets Buyout Offer From Bristol Myers for $4.8B
|
|
Oct 9
|
Bristol Myers to Buy Mirati. Why Mirati Stock Is Falling.
|
|
Oct 3
|
The 10 pharma companies participating in Medicare price negotiations
|
|
Oct 2
|
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
|
|
Oct 2
|
FDA Accepts Merck's (MRK) Filing for Sotatercept in PAH Disease
|
|
Sep 30
|
Why You Might Be Interested In Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend
|
|
Sep 28
|
3 Dividend Stocks to Buy and Hold Until Retirement
|
|
Aug 10
|
Bristol Myers Squibb Inducted into the Billion Dollar Roundtable, Expands Supplier Diversity Efforts
|